China ends global clinical trial of its Alzheimer’s drug
0
A global clinical trial of oligomannate, also known as GV-971 was terminated due to COVID-19 disruptions and a lack of funds. Read More
« Previous post:Is the economy stressing you out? Focus on what you can control | Next post: The top 5 predictions about the future of health from leaders in the space »
